We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-0.59%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$182B
AUM Growth
-$6.94B
Cap. Flow
-$2.75B
Cap. Flow %
-1.52%
Top 10 Hldgs %
16.96%
Holding
4,732
New
306
Increased
1,885
Reduced
1,854
Closed
476

Sector Composition

Rank Sector Weight
1 Technology 15.32%
2 Healthcare 10.78%
3 Financials 8.3%
4 Consumer Discretionary 7.44%
5 Communication Services 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEWJ icon
3801
iShares Currency Hedged MSCI Japan ETF
HEWJ
$728M
$409K ﹤0.01%
10,189
-209
-2% -$8.18K
AMLP icon
3802
CALL
Alerian MLP ETF
AMLP
$12.9B
$407K ﹤0.01%
+12,200
New +$407K
AOSL icon
3803
Alpha and Omega Semiconductor
AOSL
$1.01B
$407K ﹤0.01%
12,955
+1,231
+10% +$34.1K
ARQT icon
3804
Arcutis Biotherapeutics
ARQT
$3.26B
$406K ﹤0.01%
16,991
+2,367
+16% +$54K
CNXN icon
3805
PC Connection
CNXN
$2.19B
$405K ﹤0.01%
9,198
-1,130
-11% -$51.8K
NABL icon
3806
N-able
NABL
$981M
$405K ﹤0.01%
+32,551
New +$446K
TPB icon
3807
Turning Point Brands
TPB
$1.6B
$405K ﹤0.01%
8,480
+218
+3% +$10.4K
BMA icon
3808
Banco Macro
BMA
$5.84B
$403K ﹤0.01%
23,714
-1,325
-5% -$21K
SXC icon
3809
SunCoke Energy
SXC
$753M
$403K ﹤0.01%
64,056
-9,628
-13% -$66.1K
SPPI
3810
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$403K ﹤0.01%
184,925
-18,218
-9% -$49.8K
VCTR icon
3811
Victory Capital Holdings
VCTR
$6.42B
$402K ﹤0.01%
11,458
-13
-0.1% -$433
NGM
3812
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$402K ﹤0.01%
19,109
+4,296
+29% +$94.6K
ETD icon
3813
Ethan Allen Interiors
ETD
$608M
$401K ﹤0.01%
16,868
-2,203
-12% -$54.4K
RGP icon
3814
Resources Connection
RGP
$158M
$401K ﹤0.01%
25,412
-3,379
-12% -$50.8K
VGT icon
3815
Vanguard Information Technology ETF
VGT
$147B
$400K ﹤0.01%
7,976
-40
-0.5% -$2.07K
APPN icon
3816
PUT
Appian
APPN
$2.09B
$398K ﹤0.01%
4,300
-500
-10% -$55.4K
UCO icon
3817
ProShares Ultra Bloomberg Crude Oil
UCO
$372M
$398K ﹤0.01%
+18,896
New +$352K
OSPN icon
3818
OneSpan
OSPN
$601M
$397K ﹤0.01%
21,195
-5,226
-20% -$111K
RBCAA icon
3819
Republic Bancorp
RBCAA
$1.97B
$397K ﹤0.01%
7,816
+1,204
+18% +$59K
MINT icon
3820
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$396K ﹤0.01%
+3,883
New +$396K
OCUL icon
3821
Ocular Therapeutix
OCUL
$1.89B
$396K ﹤0.01%
39,510
+2,233
+6% +$25.1K
STRO icon
3822
Sutro Biopharma
STRO
$425M
$396K ﹤0.01%
2,094
+165
+9% +$31.4K
CIR
3823
DELISTED
CIRCOR International, Inc
CIR
$395K ﹤0.01%
11,950
-2,921
-20% -$93.8K
FSRD
3824
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$395K ﹤0.01%
+40,000
New +$393K
EZJ icon
3825
ProShares Ultra MSCI Japan
EZJ
$13.2M
$393K ﹤0.01%
7,929
+1,991
+34% +$96.5K

Similar funds

Credit Suisse's Q3 2021 Portfolio in Review

As of Q3 2021, Credit Suisse held 4,732 positions worth $182B, down 3.7% from $189B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse's Q3 2021 filing shows 306 new, 1,885 increased, 1,854 reduced and 476 closed positions. Its largest new stake was IHS Markit Ltd. Common Shares: 1,723,127 shares worth $201M. The largest sale was Twitter, Inc., an estimated $570M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2021 buy was IHS Markit Ltd. Common Shares: 1,723,127 shares worth $201M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $598M increase.
  • Credit Suisse's biggest Q3 2021 reduction was Twitter, Inc., cutting an estimated $570M.
  • Credit Suisse fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $321M.
  • Credit Suisse's ten largest holdings make up 17% of its $182B portfolio in Q3 2021.
  • Credit Suisse opened 306 new positions and closed 476 in Q3 2021.
  • Credit Suisse's portfolio value fell 3.7% quarter-over-quarter to $182B.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.